| |
| |
|
| Insider
Information: |
Carter Paul Rutherford |
| Relationship: |
Director |
| City: |
Uxbridge, Middlesex |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
62,305 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,081,601 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,305 |
|
|
| Total
Value |
$4,081,601 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP Commercial Ops |
2016-08-01 |
62,305 |
2014-02-10 |
0 |
Premium* |
|
|
Mallinckrodt plc |
MNK |
Director |
2022-06-16 |
0 |
2018-05-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNK |
Mallinckrodt plc |
Director |
– • – |
2022-06-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,320) |
0 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2020-05-13 |
4 |
D |
$2.96 |
$26,986 |
D/D |
(9,117) |
20,320 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
19,396 |
29,437 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2019-05-15 |
4 |
D |
$15.21 |
$135,460 |
D/D |
(8,906) |
10,041 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
18,947 |
18,947 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-08-01 |
4 |
OE |
$24.91 |
$78,255 |
D/D |
2,000 |
64,305 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-08-01 |
4 |
AS |
$79.81 |
$159,620 |
D/D |
(2,000) |
62,305 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-07-31 |
4 |
D |
$79.47 |
$104,662 |
D/D |
(1,317) |
62,305 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-07-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
63,622 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-07-01 |
4 |
OE |
$24.91 |
$49,810 |
D/D |
2,000 |
63,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-07-01 |
4 |
AS |
$83.12 |
$166,250 |
D/D |
(2,000) |
61,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-06-01 |
4 |
OE |
$24.91 |
$49,810 |
D/D |
2,000 |
63,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-06-01 |
4 |
AS |
$87.02 |
$174,040 |
D/D |
(2,000) |
61,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-05-31 |
4 |
OE |
$24.30 |
$1,934,021 |
D/D |
57,092 |
118,214 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-05-31 |
4 |
AS |
$86.85 |
$4,958,600 |
D/D |
(57,092) |
61,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-05-02 |
4 |
AS |
$88.72 |
$177,448 |
D/D |
(2,000) |
61,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-05-02 |
4 |
OE |
$24.91 |
$78,255 |
D/D |
2,000 |
63,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-04-01 |
4 |
AS |
$91.34 |
$182,680 |
D/D |
(2,000) |
61,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-04-01 |
4 |
OE |
$24.91 |
$49,810 |
D/D |
2,000 |
63,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-03-01 |
4 |
OE |
$24.91 |
$49,810 |
D/D |
2,000 |
63,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-03-01 |
4 |
AS |
$87.90 |
$175,800 |
D/D |
(2,000) |
61,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-02-16 |
4 |
D |
$91.15 |
$674,054 |
D/D |
(7,395) |
61,122 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
19,486 |
68,517 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• • – |
2016-02-15 |
4 |
A |
$76.02 |
$18,854 |
D/D |
248 |
49,031 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2016-02-01 |
4 |
AS |
$82.32 |
$164,640 |
D/D |
(2,000) |
48,783 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
